Area of research
Cancer Research · Molecular Biology
Research interest
Research focused on Cancer research and Glioblastoma, with related work in CD86, Multiple drug resistance, Pentose phosphate pathway. Notable publications include 'Construction of a competitive endogenous RNA network and analysis of potential regulatory axis targets in glioblastoma', 'Follistatin‐like protein 1 contributes to dendritic cell and T‐lymphocyte activation in nasopharyngeal carcinoma patients by altering nuclear factor κb and Jun N‐terminal kinase...', and 'The FENDRR/FOXC2 Axis Contributes to Multidrug Resistance in Gastric Cancer and Correlates With Poor Prognosis'.
Positive feedback loop of c-myc/XTP6/NDH2/NF-κB to promote malignant progression in glioblastoma
Identification of a seven-lncRNAs panel that serves as a prognosis predictor and contributes to the malignant progression of laryngeal squamous cell carcinoma
A novel microRNA panel exhibited significant potential in evaluating the progression of laryngeal squamous cell carcinoma
Construction of a competitive endogenous RNA network and analysis of potential regulatory axis targets in glioblastoma
The FENDRR/FOXC2 Axis Contributes to Multidrug Resistance in Gastric Cancer and Correlates With Poor Prognosis
Glyceraldehyde 3‐phosphate dehydrogenase modulates nonoxidative pentose phosphate pathway to provide anabolic precursors in hypoxic tumor cells
Follistatin‐like protein 1 contributes to dendritic cell and T‐lymphocyte activation in nasopharyngeal carcinoma patients by altering nuclear factor κb and Jun N‐terminal kinase expression